[Clinical experimentation with a long-acting neuroleptic fluspirilene (R 6218)].
D000328:Adult; D000368:Aged; D001321:Autistic Disorder / Q000188:drug therapy; D003702:Delusions / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D010259:Paranoid Disorders / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013141:Spiro Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D010880:Piperidines; D013141:Spiro Compounds; D014149:Tranquilizing Agents
Expérimentation clinique d'un neuroleptique à longue durée d'action: le fluspirilene (R 6218)